Literature DB >> 20724837

Nanoimaging for prion related diseases.

Alexey V Krasnoslobodtsev1, Alexander M Portillo, Tanja Deckert-Gaudig, Volker Deckert, Yuri L Lyubchenko.   

Abstract

Misfolding and aggregation of prion proteins is linked to a number of neurodegenerative disorders such as Creutzfeldt-Jacob disease (CJD) and its variants: Kuru, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia. In prion diseases, infectious particles are proteins that propagate by transmitting a misfolded state of a protein, leading to the formation of aggregates and ultimately to neurodegeneration. Prion phenomenon is not restricted to humans. There are a number of prion-related diseases in a variety of mammals, including bovine spongiform encephalopathy (BSE, also known as "mad cow disease") in cattle. All known prion diseases, collectively called transmissible spongiform encephalopathies (TSEs), are untreatable and fatal. Prion proteins were also found in some fungi where they are responsible for heritable traits. Prion proteins in fungi are easily accessible and provide a powerful model for understanding the general principles of prion phenomenon and molecular mechanisms of mammalian prion diseases. Presently, several fundamental questions related to prions remain unanswered. For example, it is not clear how prions cause the disease. Other unknowns include the nature and structure of infectious agent and how prions replicate. Generally, the phenomenon of misfolding of the prion protein into infectious conformations that have the ability to propagate their properties via aggregation is of significant interest. Despite the crucial importance of misfolding and aggregation, very little is currently known about the molecular mechanisms of these processes. While there is an apparent critical need to study molecular mechanisms underlying misfolding and aggregation, the detailed characterization of these single molecule processes is hindered by the limitation of conventional methods. Although some issues remain unresolved, much progress has been recently made primarily due to the application of nanoimaging tools. The use of nanoimaging methods shows great promise for understanding the molecular mechanisms of prion phenomenon, possibly leading toward early diagnosis and effective treatment of these devastating diseases. This review article summarizes recent reports which advanced our understanding of the prion phenomenon through the use of nanoimaging methods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724837      PMCID: PMC3268959          DOI: 10.4161/pri.4.4.13125

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  95 in total

1.  2D correlation deep UV resonance raman spectroscopy of early events of lysozyme fibrillation: kinetic mechanism and potential interpretation pitfalls.

Authors:  Victor A Shashilov; Igor K Lednev
Journal:  J Am Chem Soc       Date:  2007-12-08       Impact factor: 15.419

2.  Ultraflat transparent gold nanoplates--ideal substrates for tip-enhanced Raman scattering experiments.

Authors:  Tanja Deckert-Gaudig; Volker Deckert
Journal:  Small       Date:  2009-04       Impact factor: 13.281

3.  Direct characterization of amyloidogenic oligomers by single-molecule fluorescence.

Authors:  Angel Orte; Neil R Birkett; Richard W Clarke; Glyn L Devlin; Christopher M Dobson; David Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

4.  Assembly, tuning and use of an apertureless near field infrared microscope for protein imaging.

Authors:  Melissa Paulite; Zahra Fakhraai; Boris B Akhremitchev; Kerstin Mueller; Gilbert C Walker
Journal:  J Vis Exp       Date:  2009-11-25       Impact factor: 1.355

5.  Watching amyloid fibrils grow by time-lapse atomic force microscopy.

Authors:  C Goldsbury; J Kistler; U Aebi; T Arvinte; G J Cooper
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

Review 6.  Species barriers in prion diseases--brief review.

Authors:  R A Moore; I Vorberg; S A Priola
Journal:  Arch Virol Suppl       Date:  2005

7.  Prion species barrier between the closely related yeast proteins is detected despite coaggregation.

Authors:  Buxin Chen; Gary P Newnam; Yury O Chernoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

8.  Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance.

Authors:  John J Balbach; Aneta T Petkova; Nathan A Oyler; Oleg N Antzutkin; David J Gordon; Stephen C Meredith; Robert Tycko
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

9.  Role of intermolecular forces in defining material properties of protein nanofibrils.

Authors:  Tuomas P Knowles; Anthony W Fitzpatrick; Sarah Meehan; Helen R Mott; Michele Vendruscolo; Christopher M Dobson; Mark E Welland
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

10.  Solid-state NMR study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast prion protein Sup35p.

Authors:  Patrick C A van der Wel; Józef R Lewandowski; Robert G Griffin
Journal:  J Am Chem Soc       Date:  2007-03-31       Impact factor: 15.419

View more
  6 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Effect of electrostatics on aggregation of prion protein Sup35 peptide.

Authors:  Alexander M Portillo; Alexey V Krasnoslobodtsev; Yuri L Lyubchenko
Journal:  J Phys Condens Matter       Date:  2012-03-30       Impact factor: 2.333

3.  Polymorphism of amyloid fibrils formed by a peptide from the yeast prion protein Sup35: AFM and Tip-Enhanced Raman Scattering studies.

Authors:  Alexey V Krasnoslobodtsev; Tanja Deckert-Gaudig; Yuliang Zhang; Volker Deckert; Yuri L Lyubchenko
Journal:  Ultramicroscopy       Date:  2016-03-30       Impact factor: 2.689

4.  Nanoimaging for Molecular Pharmaceutics of Alzheimer's and other Neurodegenerative Disorders.

Authors:  Yuri L Lyubchenko
Journal:  J Mol Pharm Org Process Res       Date:  2013

5.  High resolution spectroscopy reveals fibrillation inhibition pathways of insulin.

Authors:  Tanja Deckert-Gaudig; Volker Deckert
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

6.  Spatially resolved spectroscopic differentiation of hydrophilic and hydrophobic domains on individual insulin amyloid fibrils.

Authors:  Tanja Deckert-Gaudig; Dmitry Kurouski; Martin A B Hedegaard; Pushkar Singh; Igor K Lednev; Volker Deckert
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.